CAS: 68-89-3; Metamizole Sodium

该化合物是一种非类尿类止痛剂和抗性激素化合物,具有显著的聚氨酯溶解特性,其作用机制包括主要通过环氧基gen酶(COX)途径调节抑制异丙烯合成,从而有效减轻疼痛和减少发烧,该化合物具有较高的生物利用率和快速行动,适合急性疼痛管理.代谢钠因其在治疗后期,共产物和癌症相关疼痛方面的效力而特别受重视,其强烈的止痛剂和聚氨溶液效应具有优势,在肝脏中发生代谢作用,在适当临床监督下使用时具有有详细记录的安全特征,在某些地区的使用受到限制,原因是其作用稀有但严重的不良效应,例如腺细胞病.

结构式图片

欧盟法规

C&L通报REACH预注册

上下游产品

CAS号519-98-2 4-(甲氨基)安替比林 | CAS号50-00-0 甲醛 | CAS号83-07-8 4-氨基安替比林 | CAS号58-15-1 氨基比林 | CAS号810-16-2 3H-Pyrazol-3-on... | CAS号38604-70-5 N-methyl-N-phen...

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-7301006-B2
    优先权日:2002-07-16
    标 题 :Methods and materials for the synthesis of modified peptides
    发明人:YOUNG TRAVIS G; KIESSLING LAURA L
    权利人:WISCONSIN ALUMNI RES FOUND
    摘要:Methods and protected amino acids useful as building blocks (protected monomers) for the synthesis of peptides and proteins that are selectively modified at one or more side-chain hydroxyl groups. Azide-bearing protecting groups allow the selective deprotection of side-chain hydroxyl groups of amino acids after synthesis of a peptide. Reaction conditions for removal of the azide-bearing protecting group can be selected which are substantially orthogonal to those that will remove α-amino protecting groups typically employed in peptide synthesis, such that hydroxyl groups protected with the azide-bearing protecting group remain protected during synthesis of the peptide chain. Various protecting groups which are readily available can be used for protecting potentially reactive side chain groups of amino acids in the peptide or protein to be modified. Preferred side-chain protecting groups are chemically distinguishable from the azide-bearing protecting group and substantially orthogonal reaction conditions can be selected such that side-chain protection of other amino acids is maintained when the azide-bearing protecting group is removed. The use of the azide-bearing protecting group of this invention for one or more hydroxy amino acids during peptide synthesis allows the selective unmasking of those azide-protected side-chain hydroxyl groups and selective modification of the hydroxyl groups that are selectively unmasked. The methods and materials herein are particularly used in synthesis of sulfated, phosphorylated and glycosylated peptides and proteins. Kits and methods of synthesizing a modified peptide or protein using the kits are also provided.

    专利号:US-2005101763-A1
    优先权日:2003-09-30
    标 题 :Synthesis of photolabile 2-(2-nitrophenyl)propyloxycarbonyl protected amino acids
    发明人:DELISI CHARLES P; LAURSEN RICHARD A; BHUSHAN KUMAR R
    权利人:UNIV BOSTON
    摘要:The 2-(2-nitrophenyl)propyloxycarbonyl (NPPOC) group has been introduced as a photolabile amino protecting group for amino acids to be used as building blocks in photolithographic solid-phase peptide synthesis. NPPOC-protected amino acids were found to be cleaved in the presence of UV light about twice as fast as the corresponding o-nitroveratryloxycarbonyl (NVOC)-protected amino acids. The protected amino acids are of particular use in the synthesis of peptide arrays.

    专利号:US-5175209-A
    优先权日:1987-01-06
    标题:Porous wafer for segmented synthesis of biopolymers
    发明人:BEATTIE KENNETH L; FROST III JAMES D
    权利人:BAYLOR COLLEGE MEDICINE
    摘要:A wafer for synthesizing biopolymers which includes a solid phase support material, a reaction chamber which receives and retains the support material and at least one inert porous material which allows flow through the wafer. Also included is a segmented wafer synthesis device comprising at least one, and preferably numerous, wafers for the simultaneous synthesis of multiple defined-sequenced biopolymers. Further there are process steps for synthesizing a variety of biopolymers. Synthetic polynucleotides have played a key role in studies of genetic organization through their use as primers for DNA sequencing and as hybridization probes, linkers and adapters in the cloning of genes.

    专利号:US-8008005-B2
    优先权日:2001-05-18
    标题 :Method for the synthesis of DNA sequences
    发明人:BELSHAW PETER J; SUSSMAN MICHAEL J; CERRINA FRANCESCO; FLICKINGER SHANE T
    权利人:WISCONSIN ALUMNI RES FOUND
    摘要:A method is disclosed for the direct synthesis of double stranded DNA molecules of a variety of sizes and with any desired sequence. The DNA molecule to be synthesis is logically broken up into smaller overlapping DNA segments. A maskless microarray synthesizer is used to make a DNA microarray on a substrate in which each element or feature of the array is populated by DNA of a one of the overlapping DNA segments. The DNA segments are released from the substrate and held under conditions favoring hybridization of DNA, under which conditions the segments will spontaneously hybridize together to form the desired DNA construct. This method makes possible the remote assembly of DNA sequence, through a process analogous to facsimile transmission of documents, since the information on DNA to be made can be transmitted remotely to an instrument which can then synthesize any needed DNA sequence from the information.

    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:US-6579725-B1
    优先权日:1999-03-05
    标题 :Linkers for synthesis of oligosaccharides on solid supports
    发明人:SEEBERGER PETER H; ANDRADE RODRIGO B
    权利人:MASSACHUSETTS INST TECHNOLOGY
    摘要:The present invention relates to versatile linkers for tethering a molecule to a solid support, e.g., for tethering a monomer, oligomer or polymer to a solid support, which are stable to a wide range of reaction conditions, but can be cleaved under well-defined conditions, thereby liberating the molecule from the solid support. Preferably, the linkers are used to tether to the solid support unprotected, partially-protected or fully-protected monosaccharides or oligosaccharides, or unprotected, partially-protected or fully-protected glycoconjugates. The linkers of the present invention may be used to tether to solid supports building blocks useful in the assembly of libraries of other types of small molecules. The present invention also relates to a molecule or plurality of molecules tethered to the solid support via a linker or linkers of the present invention. The present invention also relates to processes for synthesizing molecules, e.g., monomers, oligomers or polymers, on a solid support, wherein a starting material in the synthesis of the molecule, intermediates in the synthesis of the molecule, and the molecule itself are tethered to the solid support during the process via one of the linkers of the present invention. In certain processes of the present invention, the molecule is liberated from the solid support by cleavage of the linker of the present invention.
    上海医药集团股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sphchina.com
    电话: 021-65542229👤
    📞上海医药集团股份有限公司 ⚠️参考联系方式

    销售电话:021-65542229
    邮箱:sales@api-pharm-sh.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    无锡桥威国际贸易有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.choriway.com
    电话: 0510-82606408👤
    📞无锡桥威国际贸易有限公司 ⚠️参考联系方式

    销售电话:0510-82606408
    邮箱:sales@choriway.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    杭州维华生物技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.viwachina.com
    电话: 86-0571-56003631 56003555👤
    📞杭州维华生物技术有限公司 ⚠️参考联系方式

    销售电话:86-0571-56003631 56003555
    邮箱:sales@viwachina.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Polzin A, Richter S, Schrör K, Rassaf T, Merx MW, Kelm M, Hohlfeld T, Zeus T. Prevention of dipyrone (metamizole) induced inhibition of aspirin antiplatelet effects. Thromb Haemost. 2015 Jul;114(1):87-95. doi: 10.1160/TH14-11-0922. Epub 2015 Mar 19. doi: 10.1111/1440-1681.12347. doi: 10.1007/s00482-014-1490-7. Review. German. doi: 10.1111/vec.12336. Epub 2015 Jun 25. doi: 10.1111/bcpt.12312. Epub 2014 Oct 8. doi: 10.1111/bph.12717.
    7: Ramacciotti AS, Soares BG, Atallah AN. WITHDRAWN: Dipyrone for acute primary headaches. Cochrane Database Syst Rev. 2014 Jul 11;(7):CD004842. doi: 10.1002/14651858.CD004842.pub3. Review. doi: 10.1111/bcp.12628. Epub 2015 Jul 6. Review.
    9: Ertin IH, Gunduz O, Ulugol A. Contribution of nociceptin/orphanin FQ receptors to the anti-nociceptive and hypothermic effects of dipyrone. Acta Neuropsychiatr. 2015 Feb;27(1):48-52. doi: 10.1017/neu.2014.38. Epub 2014 Dec 3. doi: 10.1111/bph.13129. Epub 2015 Apr 24.

    合成参考文献


    参考文献:10.1021/jm200531f
    摘要:dos Santos JL, Lanaro C, Lima LM, Gambero S, Franco-Penteado CF, Alexandre-Moreira MS, Wade M, Yerigenahally S, Kutlar A, Meiler SE, Costa FF, Chung M. Design, synthesis, and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms. J Med Chem. 2011 Aug 25;54(16):5811–9. doi: 10.1021/jm200531f.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知